Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Sponsor
National Taiwan University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00155337
Collaborator
(none)
40
1
40
1
Study Details
Study Description
Brief Summary
Photodynamic therapy for oral leukoplakia and erythroleukoplakia
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
Photodynamic therapy for oral leukoplakia and erythroleukoplakia
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
Study Start Date
:
Aug 1, 2004
Actual Primary Completion Date
:
Dec 1, 2007
Actual Study Completion Date
:
Dec 1, 2007
Outcome Measures
Primary Outcome Measures
- End of 8 treatments []
Secondary Outcome Measures
- Regression of lesions []
Eligibility Criteria
Criteria
Ages Eligible for Study:
20 Years
to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patients with leukoplakia or erythroleukoplakia
Exclusion Criteria:
- oral cancers
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | National Taiwan University Hospital | Taipei | Taiwan | 100 |
Sponsors and Collaborators
- National Taiwan University Hospital
Investigators
- Principal Investigator: Chun-Pin Chiang, DMSc, National Taiwan University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00155337
Other Study ID Numbers:
- 9361700753
First Posted:
Sep 12, 2005
Last Update Posted:
Dec 21, 2012
Last Verified:
Dec 1, 2012
Keywords provided by ,
,
Additional relevant MeSH terms: